Thienopyrimidinones for treatment of inflammatory disorders and cancers
NZ575394A
Compositions of chk1 inhibitors and cyclodextrin
MX2008015696A
Substituted phenyl acetic acids as dp-2 antagonists.
CN101490001A
Substituted phenyl acetic acids as DP-2 antagonists
WO2007044756A2
Monoclonal antibodies recognizing human ccr8
NZ561458A
Heteroaryl urea derivatives useful for inhibiting CHK1
WO2006089106A2
Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
CA2590284A1
Recombinant method for making multimeric proteins
WO2006062690A2
Phosphatidylserine synthase materials and methods
MX2007002040A
Compounds useful for inhibiting chk1.
AU2005202977A1
Tankyrase2 Materials and Methods
CA2573063A1
Compounds useful for inhibiting chk1
CN101006075A
Bisarylurea derivatives useful for inhibiting CHK1
EP1750715A1
Methods for treating mast cell disorders
ME02695B
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
CN1976911A
Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
EP1740561A2
Arylphenylamino-and arylphenylether-sulfide derivatives, useful for the treatment of inflammatory and immune diseases, and pharmaceutical compositions containing them
WO2005097090A2
AGENTS THAT DISRUPT PSD95 - nNOS INTERACTION, COMPOSITIONS CONTAINING THE SAME, AND THERAPEUTIC USES THEREOF
